Insights

Expanding Therapeutic Portfolio Spur Therapeutics is venturing into developing therapies for more widespread conditions like Parkinson's, dementia, and cardiovascular diseases, indicating opportunities to reach a larger patient population with innovative treatments.

Growing Revenue Potential With a revenue range of $10M - $50M, Spur Therapeutics showcases financial stability and potential for growth, demonstrating a solid foundation for prospective sales partnerships and collaborations.

High-Impact Genetic Medicine The focus on genetic medicine and optimizing product candidates for improved genetic expression positions Spur Therapeutics as a trailblazer in the biotechnology research industry, offering unique and high-impact solutions.

Strategic Technology Integration Utilizing a tech stack that includes Google Analytics, Amazon Web Services, and Netlify, Spur Therapeutics shows a commitment to leveraging advanced technologies, presenting opportunities for tech-oriented collaborations and integrations.

Competitive Market Positioning Compared to similar companies with varying employee sizes and revenues, Spur Therapeutics stands out in the biotechnology landscape, indicating potential differentiation strategies and competitive advantages to explore in sales initiatives.

Spur Therapeutics Tech Stack

Spur Therapeutics uses 8 technology products and services including Google Analytics, OneTrust, Font Awesome, and more. Explore Spur Therapeutics's tech stack below.

  • Google Analytics
    Analytics
  • OneTrust
    Cookie Compliance
  • Font Awesome
    Font Scripts
  • Open Graph
    Miscellaneous
  • Eleventy
    Page Builders
  • Netlify
    Platform As A Service
  • Amazon Web Services
    Platform As A Service
  • HSTS
    Security

Media & News

Spur Therapeutics's Email Address Formats

Spur Therapeutics uses at least 2 format(s):
Spur Therapeutics Email FormatsExamplePercentage
First.Last@freeline.lifeJohn.Doe@freeline.life
97%
First.Middle@freeline.lifeJohn.Michael@freeline.life
1%
FirstMiddle.Last@freeline.lifeJohnMichael.Doe@freeline.life
1%
Last@freeline.lifeDoe@freeline.life
1%

Frequently Asked Questions

Where is Spur Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Spur Therapeutics's main headquarters is located at Gunnels Wood Road Stevenage, England GB. The company has employees across 5 continents, including AsiaEuropeNorth America.

What is Spur Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Spur Therapeutics's official website is spurtherapeutics.com and has social profiles on LinkedIn.

How much revenue does Spur Therapeutics generate?

Minus sign iconPlus sign icon
As of January 2025, Spur Therapeutics's annual revenue reached $35M.

What is Spur Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Spur Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Spur Therapeutics have currently?

Minus sign iconPlus sign icon
As of January 2025, Spur Therapeutics has approximately 329 employees across 5 continents, including AsiaEuropeNorth America. Key team members include Chief Executive Officer: M. P.Chief Financial Officer: P. S.Chief Financial Officer: P. S.. Explore Spur Therapeutics's employee directory with LeadIQ.

What industry does Spur Therapeutics belong to?

Minus sign iconPlus sign icon
Spur Therapeutics operates in the Biotechnology Research industry.

What technology does Spur Therapeutics use?

Minus sign iconPlus sign icon
Spur Therapeutics's tech stack includes Google AnalyticsOneTrustFont AwesomeOpen GraphEleventyNetlifyAmazon Web ServicesHSTS.

What is Spur Therapeutics's email format?

Minus sign iconPlus sign icon
Spur Therapeutics's email format typically follows the pattern of . Find more Spur Therapeutics email formats with LeadIQ.

How much funding has Spur Therapeutics raised to date?

Minus sign iconPlus sign icon
As of January 2025, Spur Therapeutics has raised $50M in funding. The last funding round occurred on Jun 17, 2024 for $50M.

When was Spur Therapeutics founded?

Minus sign iconPlus sign icon
Spur Therapeutics was founded in 2015.
Spur Therapeutics

Spur Therapeutics

Biotechnology ResearchEngland, United Kingdom201-500 Employees

Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. 

Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. 

Toward life-changing therapies, and brighter futures.  
Toward More™

Section iconCompany Overview

Headquarters
Gunnels Wood Road Stevenage, England GB
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2015
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $50M

    Spur Therapeutics has raised a total of $50M of funding over 1 rounds. Their latest funding round was raised on Jun 17, 2024 in the amount of $50M.

  • $10M$50M

    Spur Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $50M

    Spur Therapeutics has raised a total of $50M of funding over 1 rounds. Their latest funding round was raised on Jun 17, 2024 in the amount of $50M.

  • $10M$50M

    Spur Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.